Cheryl Gault, Chief Operating Officer at Rapport Therapeutics, sold RAPP on Sep 30, 2026
Data as of Oct 16
▼ SELL$262K7,925 shares at $33.04Cheryl Gault Chief Operating OfficerRAPP Rapport Therapeutics, Inc.
- Traded
- Sep 30, 2026
- Disclosed
- Oct 1, 2026
- Filed
- 1 day after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
RAPP since disclosure
−16.0%
after the sale
Similar stocks (SPY) since disclosure
−0.1%
S&P 500 (SPY)
Change in closing price from Oct 1, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLCheryl Gault Chief Operating OfficerRAPP Rapport Therapeutics, Inc.$70Kdisclosed Oct 1 · filed 1 day after the trade